MIRA Pharmaceuticals, Inc.
MIRA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $20,554 | $16,312 | $17,606 |
| - Cash | $2,642 | $730 | $1,206 | $2,833 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $19,823 | $15,106 | $14,773 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$1,138 | -$1,546 | -$1,805 | -$2,438 |
| % Margin | – | – | – | – |
| Net Income | -$22,694 | -$1,538 | -$1,784 | -$2,400 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.18 | -0.091 | -0.11 | -0.16 |
| % Growth | -1,203.9% | 17.7% | 31.3% | – |
| Operating Cash Flow | -$1,097 | -$800 | -$1,630 | -$1,805 |
| Capital Expenditures | $0 | $0 | -$0 | $0 |
| Free Cash Flow | -$1,097 | -$800 | -$1,630 | -$1,805 |